Neurotoxicity induced by cefepime use in patients with chronic renal failure

Zhang Yan,Zhu Haiying,Cheng Hongqin,Chu Yanqi,Yang Yiwei,Fu Qiang
DOI: https://doi.org/10.3969/j.issn.1008-5734.2009.06.005
2009-01-01
Abstract:Objective: To investigate the clinical features of neurotoxicity induced by cefepime use in patients with chronic renal failure in order to provide the basis for rational use of cefepime.Methods:In January-April 2009,6 patients with chronic renal failure receiving cefepime were enrolled in the investigation.The time to neurological symptom onset,clinical presentations,and the time to the symptom relief were investigated.The liver and renal function,blood glucose,electrolyte,pH,pO2,and pCO2 levels were measured.Results: Six patients comprised 3 men and 3 women aged 54~92 years [avaergy age(74±13)].All 6 patients received an IV infusion of cefepime 2~8 g daily for pulmonary infections.Neurological symptoms occurred in 1~3 days after initiation of cefepime infusion.Clinical presentations included agitation,verbal incoherence,delirium,confusion,somnolence,and 1 case of involuntary tremor of the extremities.The symptoms relieved within 3 days after cefepime discontinuation and symptomatic therapy.There was no marked difference in biochemical values in all 6 patients before and after cefipime administration.Conclusion: Neurotoxicity may occur in patients with chronic renal failure receiving an IV infusion of cefepime;care should be taken when using cefepime to treat patients with renal failure.
What problem does this paper attempt to address?